Shares of Ardent Health, Inc. (NYSE:ARDT – Get Free Report) saw unusually-high trading volume on Thursday . Approximately 675,650 shares traded hands during trading, an increase of 63% from the previous session’s volume of 414,281 shares.The stock last traded at $8.2450 and had previously closed at $7.83.
Wall Street Analyst Weigh In
ARDT has been the topic of a number of recent analyst reports. Royal Bank Of Canada lowered their target price on Ardent Health from $14.00 to $13.00 and set an “outperform” rating on the stock in a research note on Monday, March 9th. UBS Group raised their target price on Ardent Health from $13.00 to $13.50 and gave the stock a “buy” rating in a research report on Thursday, May 7th. Leerink Partners decreased their target price on Ardent Health from $16.00 to $15.00 and set an “outperform” rating for the company in a research report on Friday, March 6th. Zacks Research raised Ardent Health from a “strong sell” rating to a “hold” rating in a research report on Wednesday, March 25th. Finally, Wall Street Zen raised Ardent Health from a “hold” rating to a “buy” rating in a research report on Saturday, May 16th. Seven research analysts have rated the stock with a Buy rating, five have given a Hold rating and two have assigned a Sell rating to the stock. According to MarketBeat, the stock currently has an average rating of “Hold” and a consensus target price of $14.21.
View Our Latest Report on ARDT
Ardent Health Stock Performance
Ardent Health (NYSE:ARDT – Get Free Report) last announced its quarterly earnings results on Tuesday, May 5th. The company reported $0.28 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.18 by $0.10. Ardent Health had a net margin of 2.09% and a return on equity of 13.85%. The firm had revenue of $1.60 billion for the quarter, compared to the consensus estimate of $1.58 billion. Ardent Health has set its FY 2026 guidance at 0.900-1.270 EPS. As a group, equities research analysts expect that Ardent Health, Inc. will post 1.12 EPS for the current year.
Institutional Investors Weigh In On Ardent Health
A number of institutional investors and hedge funds have recently modified their holdings of ARDT. Goldentree Asset Management LP increased its stake in Ardent Health by 99.7% in the 4th quarter. Goldentree Asset Management LP now owns 2,303,113 shares of the company’s stock worth $20,302,000 after acquiring an additional 1,150,000 shares during the last quarter. Goldman Sachs Group Inc. raised its holdings in shares of Ardent Health by 1,684.9% in the 1st quarter. Goldman Sachs Group Inc. now owns 767,862 shares of the company’s stock valued at $10,558,000 after acquiring an additional 724,841 shares in the last quarter. Ameriprise Financial Inc. raised its holdings in shares of Ardent Health by 75.6% in the 2nd quarter. Ameriprise Financial Inc. now owns 1,634,822 shares of the company’s stock valued at $22,332,000 after acquiring an additional 703,739 shares in the last quarter. Bridgeway Capital Management LLC increased its position in shares of Ardent Health by 108.2% in the fourth quarter. Bridgeway Capital Management LLC now owns 946,571 shares of the company’s stock worth $8,358,000 after purchasing an additional 491,961 shares during the last quarter. Finally, Hotchkis & Wiley Capital Management LLC bought a new position in shares of Ardent Health in the third quarter worth approximately $6,377,000.
About Ardent Health
Ardent Health, listed on the New York Stock Exchange under the ticker ARDT, is a healthcare delivery company focused on acquiring, developing and managing acute care hospitals and complementary outpatient facilities across the United States. The company’s integrated platform encompasses both inpatient and outpatient services, designed to provide end-to-end care solutions and address the full continuum of patient needs.
Through its network, Ardent Health operates general hospitals, emergency departments, ambulatory surgery centers, urgent care clinics, rehabilitation and post-acute care facilities.
Further Reading
- Five stocks we like better than Ardent Health
- The Great AI Server Rotation Puts Hewlett Packard Enterprise and Super Micro in Focus
- Generac’s AI Power Pivot Raises a Bigger Question About Data Center Demand
- Medtronic Bottoms, Healthy Rebound Ahead
- GitLab’s Price Recovery Gains Traction—Time to Get On Board?
Receive News & Ratings for Ardent Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ardent Health and related companies with MarketBeat.com's FREE daily email newsletter.
